Unlocking Efficiency and Quality: What is New in Phoenix™ 8.4?
Join us for an exclusive webinar as Certara introduces the highly anticipated version 8.4 of…
CertaraJune 5, 2023
Leveraging Pharmacokinetic Modeling & Scientific Communications Expertise Advances Sarcoidosis Drug Program
Certara's support, from dose optimization to medical writing, helps pharmaceutical companies advance their research, make…
CertaraJune 1, 2023
QSP Designer: Quantitative systems pharmacology modeling with modular biological process map notation and multiple language code generation
Typical Quantitative Systems Pharmacology (QSP) workflows involve discussion of biology, supported by graphical diagrams, followed…
CertaraMay 25, 2023
Dose Optimization: Getting it Right for Vulnerable Populations
By: Justin Hay & Frank Engler Pandemics amplify existing strengths and vulnerabilities—not only highlighting who…
CertaraMay 22, 2023
Japan’s Approach to Pediatric Drug Development: What You Need to Know
Access to safe and effective medications is critical for pediatric patients, yet 60-70% of medicines…
CertaraMay 22, 2023
Creation of a Scientific Hypothesis – For optimization of drug compounds | Chemaxon
A well-formulated hypothesis is essential to the success of the drug discovery process.
CertaraMay 19, 2023
Key Properties in Drug Design | Predicting Lipophilicity, pKa and Solubility
Discover how Chemaxon's predictive models for lipophilicity, pKa, and solubility can accurately predict key molecular…
CertaraMay 12, 2023
